Therapeutic areas such as rheumatology, dermatology, and gastroenterology have been the focus of research for biopharma companies in recent years. However, despite the emergence of new and promising drugs, there remain hurdles in addressing autoimmune conditions including tailoring treatments to complement the heterogenous pathophysiologic mechanisms to each patient and anticipating and addressing primary nonresponse and loss of response to current or new therapies.

Inova, together with BIO is hosting a 4-day Immunology Virtual Partnering Event, to help facilitate networking between researchers, biotech companies, and business development executives from biopharmaceutical companies.